Table 1.
Relationship between Musashi-1 expression and clinicopathologic features of patients with endometrioid adenocarcinoma
| Variable | Cases(n = 148) | Musashi-1 staining | P value | |
|---|---|---|---|---|
|
| ||||
| Negative (n = 20) | Positive (n = 128) | |||
| Previous pregnancy | ||||
| Yes | 130 | 16 (12.31%) | 114 (87.69%) | 0.279 |
| No | 18 | 4 (22.22%) | 14 (77.78%) | |
| Menopause | ||||
| Yes | 94 | 16 (17.02%) | 78 (82.98%) | 0.087 |
| No | 54 | 4 (7.41%) | 50 (92.59%) | |
| FIGO staging | ||||
| Stage I | 128 | 20 (15.62%) | 108 (84.38%) | 0.043 |
| Stage II | 11 | 0 (0%) | 11 (100%) | |
| Stage III | 9 | 0 (0%) | 9 (100%) | |
| Grade | ||||
| G1 | 67 | 19 (28.36%) | 48(71.64%) | 0.000 |
| G2 | 66 | 1 (1.52%) | 65(98.48%) | |
| G3 | 15 | 0 (0%) | 15(100%) | |
| Vascular invasion | ||||
| Yes | 28 | 0 (0%) | 28 (100%) | 0.011 |
| No | 120 | 20 (16.67%) | 100 (83.33%) | |
| Lymphatic metastasis | ||||
| Yes | 5 | 0 (0%) | 5 (100%) | 0.224 |
| No | 143 | 20 (13.99%) | 123 (86.01%) | |